Price Target. The average one-year price target for Plus Therapeutics, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's. Logo Plus Therapeutics, Inc. Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is developing targeted radiotherapeutics with. Compared to the closing price on Tuesday 08/13/ on BTT of $, this is a drop of %. There are M shares outstanding in Plus Therapeutics Inc. The current price of PSTV is USD — it has increased by % in the past 24 hours. Watch PLUS THERAPEUTICS, Inc. stock price performance more closely on. Track Plus Therapeutics Inc (PSTV) Stock Price, Quote, latest community messages, chart, news and other stock related information.
PLUS THERAPEUTICS, Inc. Common Stock PSTV ; Loading chart ; About PLUS THERAPEUTICS, Inc. Common Stock (PSTV). Loading info ; Key Statistics. Loading info. Price Target. The average one-year price target for Plus Therapeutics, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's. PSTV | Complete Plus Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Key Stock Data · P/E Ratio (TTM). N/A · EPS (TTM). $ · Market Cap. $ M · Shares Outstanding. M · Public Float. M · Yield. PSTV is not. Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The company is headquartered in Austin, Texas and currently employs 20 full-time. Alaunos Therapeutics Inc. $ TCRT % ; Phio Pharmaceuticals Corp. $ PHIO % ; Pulmatrix Inc. $ PULM % ; Kiora Pharmaceuticals Inc. $ The average price target for Plus Therapeutics Inc is $ This is based on 3 Wall Streets Analysts month price targets, issued in the past 3 months. The. While ratings are subjective and will change, the latest Plus Therapeutics (PSTV) rating was a reiterated with a price target of $ to $ The current. Plus Therapeutics, Inc. (PSTV). Plus Therapeutics (PSTV on Nasdaq) is a U.S. clinical-stage pharmaceutical company, backed by talented executives and a nationwide network of scientists.
Logo Plus Therapeutics, Inc. Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is developing targeted radiotherapeutics with. Plus Therapeutics (PSTV on Nasdaq) is a U.S. clinical-stage pharmaceutical company, backed by talented executives and a nationwide network of scientists. The Plus Therapeutics, Inc. stock price fell by % on the last day (Thursday, 22nd Aug ) from $ to $ It has now fallen 3 days in a row. During. The Plus Therapeutics EPS is Is Plus Therapeutics (PSTV) A Good Investment? Based on performance across. View Plus Therapeutics, Inc. PSTV stock quote prices, financial information, real-time forecasts, and company news from CNN. Plus Therapeutics Inc ; Sep PM · Plus Therapeutics Presents Cancer Treatment Data at Conference. (Exec Edge) +% ; AM · Plus Therapeutics. Discover real-time PLUS THERAPEUTICS, Inc. Common Stock (PSTV) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Plus Therapeutics Inc PSTV:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/08/23 · 52 Week Low · in cancer radiotherapeutics. © Plus Therapeutics Inc. All rights reserved. footer-logo. Power and precision in cancer radiotherapeutics.
Plus Therapeutics Market Cap | PSTV ; Universe Pharmaceuticals INC (UPC), China, $B ; Kiora Pharmaceuticals (KPRX), United States, $B ; Avalo. Plus Therapeutics is focused on developing innovative, targeted radiotherapeutics for adults & children with difficult-to-treat cancer. PSTV support price is $ and resistance is $ (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility. Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients. Compared to the closing price on Tuesday 08/13/ on BTT of $, this is a drop of %. There are M shares outstanding in Plus Therapeutics Inc.